Health Care & Life Sciences » Pharmaceuticals | Wakamoto Pharmaceutical Co. Ltd.

Wakamoto Pharmaceutical Co. Ltd.

Wakamoto Pharmaceutical Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY5.23
Market Cap
JPY9.41 B
Shares Outstanding
34.84 M
Public Float
15.51 M

Profile

Address
2-2-2 Nihonbashi Hon-cho
Tokyo Tokyo 103
Japan
Employees -
Website http://www.wakamoto-pharm.co.jp
Updated 07/08/2019
Wakamoto Pharmaceutical Co., Ltd. engages in the manufacture and sale of ethical and non-prescription drugs. Its operations are carried out through the following segments: Medicine, Non-Prescription Drugs, Special Sales and Others. The Medicine segment provides ethical drugs.

Financials

View All
Created with Highcharts 5.0.14Wakamoto Pharmaceutical Co. Ltd.Net Income. Fiscal year is April-March. All values JPY Millions.84584583832121959512612618118120142015201620172018201902004006008001000
Created with Highcharts 5.0.14Wakamoto Pharmaceutical Co. Ltd.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.10 31810 31810 61310 61311 19411 19410 83310 83310 90110 90110 74210 74220142015201620172018201902.5k5k7.5k10k12.5k

Nobuyuki Kamiya
Chairman
Yoshihiro Horio
President & Representative Director